{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/115703"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/115703","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Computational imaging and analysis in breast cancer","abstract":"The conventional pathologic analysis of malignancies involves a qualitative characterization and integration of several factors including tumor size, general degree of differentiation, tumor heterogeneity, mitotic rate, and lymphovascular invasion. For some cancers, biomarkers such as hormone receptor expression or receptor kinase over-expression can provide additional prognostic and therapeutic guidance. Unfortunately, all of these qualitative histologic approaches, while generally accepted for directing patient care, often exhibit significant inter-observer variability resulting in inconsistent inter- and intra-institutional predictions of tumor behavior (including metastases and/or recurrence), resulting in incorrect diagnoses or treatment. Because cellular morphology is an integrated reflection of genetic and epigenetic expression, we hypothesize that a more accurate quantitative accounting and measurement of histologic features can provide a more robust and reliable prediction of tumor behavior. Computational imaging utilizes software to augment or replace the role of traditional optical elements in imaging systems and has an ability to significantly increase the accuracy, robustness and cost-efficiency of digital pathology. In this thesis, we develop and test three novel computational imaging algorithms including, to the best of our knowledge, the first system for lensless computational imaging through deep learning. We then test our hypothesis by applying augmented image retrieval, analysis algorithms, and machine learning on a validated dataset of breast cancer images where the clinical outcomes of the primary tumor are known. In particular, we analyze algorithms related to identifying mitoses as a central proof of concept.","abstract_html":"The conventional pathologic analysis of malignancies involves a qualitative characterization and integration of several factors including tumor size, general degree of differentiation, tumor heterogeneity, mitotic rate, and lymphovascular invasion. For some cancers, biomarkers such as hormone receptor expression or receptor kinase over-expression can provide additional prognostic and therapeutic guidance. Unfortunately, all of these qualitative histologic approaches, while generally accepted for directing patient care, often exhibit significant inter-observer variability resulting in inconsistent inter- and intra-institutional predictions of tumor behavior (including metastases and/or recurrence), resulting in incorrect diagnoses or treatment. Because cellular morphology is an integrated reflection of genetic and epigenetic expression, we hypothesize that a more accurate quantitative accounting and measurement of histologic features can provide a more robust and reliable prediction of tumor behavior. Computational imaging utilizes software to augment or replace the role of traditional optical elements in imaging systems and has an ability to significantly increase the accuracy, robustness and cost-efficiency of digital pathology. In this thesis, we develop and test three novel computational imaging algorithms including, to the best of our knowledge, the first system for lensless computational imaging through deep learning. We then test our hypothesis by applying augmented image retrieval, analysis algorithms, and machine learning on a validated dataset of breast cancer images where the clinical outcomes of the primary tumor are known. In particular, we analyze algorithms related to identifying mitoses as a central proof of concept.","abstract_has_math":false,"creators":["Lee, Justin Wu"],"institution":"Massachusetts Institute of Technology","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Harvard--MIT Program in Health Sciences and Technology.","school":null,"contributors":[],"advisors":["George Barbastathis."],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-07-22T22:22:10Z","subjects":["Harvard--MIT Program in Health Sciences and Technology."],"languages":["eng"],"rights":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."],"rights_urls":["http://dspace.mit.edu/handle/1721.1/7582"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1721.1/115703","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["George Barbastathis."]},{"key":"dc:contributor.department","label":"Department","values":["Harvard--MIT Program in Health Sciences and Technology."]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Harvard--MIT Program in Health Sciences and Technology."]},{"key":"dc:creator","label":"Author","values":["Lee, Justin Wu"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2018-05-23T16:31:01Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2018-05-23T16:31:01Z"]},{"key":"dc:date.issued","label":"Date","values":["2018"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Harvard--MIT Program in Health Sciences and Technology."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://dspace.mit.edu/handle/1721.1/7582"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1721.1/115703"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis: Ph. D. in Biomedical Engineering, Harvard-MIT Program in Health Sciences and Technology, 2018.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 125-136)."]},{"key":"dc:description.abstract","label":"Abstract","values":["The conventional pathologic analysis of malignancies involves a qualitative characterization and integration of several factors including tumor size, general degree of differentiation, tumor heterogeneity, mitotic rate, and lymphovascular invasion. For some cancers, biomarkers such as hormone receptor expression or receptor kinase over-expression can provide additional prognostic and therapeutic guidance. Unfortunately, all of these qualitative histologic approaches, while generally accepted for directing patient care, often exhibit significant inter-observer variability resulting in inconsistent inter- and intra-institutional predictions of tumor behavior (including metastases and/or recurrence), resulting in incorrect diagnoses or treatment. Because cellular morphology is an integrated reflection of genetic and epigenetic expression, we hypothesize that a more accurate quantitative accounting and measurement of histologic features can provide a more robust and reliable prediction of tumor behavior. Computational imaging utilizes software to augment or replace the role of traditional optical elements in imaging systems and has an ability to significantly increase the accuracy, robustness and cost-efficiency of digital pathology. In this thesis, we develop and test three novel computational imaging algorithms including, to the best of our knowledge, the first system for lensless computational imaging through deep learning. We then test our hypothesis by applying augmented image retrieval, analysis algorithms, and machine learning on a validated dataset of breast cancer images where the clinical outcomes of the primary tumor are known. In particular, we analyze algorithms related to identifying mitoses as a central proof of concept."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Ph. D. in Biomedical Engineering"]},{"key":"dc:title","label":"Title","values":["Computational imaging and analysis in breast cancer"]}]}],"canonical_facts":{"dc:contributor.advisor":["George Barbastathis."],"dc:contributor.department":["Harvard--MIT Program in Health Sciences and Technology."],"dc:contributor.other":["Harvard--MIT Program in Health Sciences and Technology."],"dc:creator":["Lee, Justin Wu"],"dc:date.accessioned":["2018-05-23T16:31:01Z"],"dc:date.available":["2018-05-23T16:31:01Z"],"dc:date.issued":["2018"],"dc:description":["Thesis: Ph. D. in Biomedical Engineering, Harvard-MIT Program in Health Sciences and Technology, 2018.","Cataloged from PDF version of thesis.","Includes bibliographical references (pages 125-136)."],"dc:description.abstract":["The conventional pathologic analysis of malignancies involves a qualitative characterization and integration of several factors including tumor size, general degree of differentiation, tumor heterogeneity, mitotic rate, and lymphovascular invasion. For some cancers, biomarkers such as hormone receptor expression or receptor kinase over-expression can provide additional prognostic and therapeutic guidance. Unfortunately, all of these qualitative histologic approaches, while generally accepted for directing patient care, often exhibit significant inter-observer variability resulting in inconsistent inter- and intra-institutional predictions of tumor behavior (including metastases and/or recurrence), resulting in incorrect diagnoses or treatment. Because cellular morphology is an integrated reflection of genetic and epigenetic expression, we hypothesize that a more accurate quantitative accounting and measurement of histologic features can provide a more robust and reliable prediction of tumor behavior. Computational imaging utilizes software to augment or replace the role of traditional optical elements in imaging systems and has an ability to significantly increase the accuracy, robustness and cost-efficiency of digital pathology. In this thesis, we develop and test three novel computational imaging algorithms including, to the best of our knowledge, the first system for lensless computational imaging through deep learning. We then test our hypothesis by applying augmented image retrieval, analysis algorithms, and machine learning on a validated dataset of breast cancer images where the clinical outcomes of the primary tumor are known. In particular, we analyze algorithms related to identifying mitoses as a central proof of concept."],"dc:description.degree":["Ph. D. in Biomedical Engineering"],"dc:identifier.uri":["http://hdl.handle.net/1721.1/115703"],"dc:language.iso":["eng"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission."],"dc:rights.uri":["http://dspace.mit.edu/handle/1721.1/7582"],"dc:subject":["Harvard--MIT Program in Health Sciences and Technology."],"dc:title":["Computational imaging and analysis in breast cancer"],"dc:type":["Thesis"]},"updated_at":"2026-07-22T22:22:10Z"}